Prof. Erdal Karaöz finished his university education at Dicle University in 1986 , and completed his Doctorate in the Department of Histology and Embryology at Gazi University’s Faculty of Medicine in 1994. He received the titles of Associate Professor and Professor in 1996 and 2002, respectively. Having worked in “Stem Cell, Tissue Engineering and Gene Therapies” since 2000, Prof. Erdal Karaöz carried out studies in “Embryonic Stem Cell and Islet Transplantation” at Harvard University in Boston, USA in 2005. Prof. Erdal Karaöz has 4 published books, 158 published articles (102 of which are international articles), and he is the author of chapters in 11 books ( 7 of which are international). In 2007, he founded “Kocaeli University (KOU) Stem Cell and Gene Therapies Research and Application Center” (KÖGEM) which is Turkey’s first corporate R&D center in its field. During his time at KÖGEM, he organized a total of 23 nationally and internationally recognized courses on “Stem Cell, Tissue Engineering and Endometrium-Embryo Co-Culture”. Within this period, he served as a coordinator, researcher and advisor on many national and international projects, including 30 TUBITAK projects.
Prof. Erdal Karaöz
He worked as the Founding President of the Stem Cell Department at the Institute of Health Sciences, Kocaeli University in 2010, and paved the way for the start of the first Postgraduate Program on “Stem Cell” in Turkey. He retired from this role at his own request on 1 October 2014 and, afterwards, he started to work as the Supervisor of Regenerative Medicine, Stem Cell Production Centers at Liv Hospital, Istanbul. In addition to peer-reviewing for many international scientific journals, Prof. Erdal Karaöz is on the editorial board of some of these journals. He serves as an assistant editor for the “Stem Cell Treatments” section of Frontiers in Cell and Developmental Biology Journal.
Prof. Karaöz served as the founding board chairman of the “The Society of Stem Cell and Cellular Treatments” from 2013-2016. Prof. Karaöz mainly conducts R&D studies on beta-cell replacement applications with embryonic and induced pluripotent stem cells (iPSCs) in the treatment of diabetes, as well as on the immunosuppressive, anti-inflammatory, anti-apoptotic, neovascularization and fine structure characteristics of Mesenchymal Stem Cells obtained from various tissues and organs. He continues to work as a consultant in the process of establishing many national and international stem cell laboratories. Today, he manages the processes requiring or not requiring ministerial approval to assist people with various diseases to benefit from cellular therapy options with human-transferable cells produced at the GMP (Good Manufacture Practice) Lab of the Regenerative Medicine Center under his directorship within Private Liv Hospital. Prof. Karaöz took part in several Ministry of Health-approved clinical trial and research projects entitled the Allogeneic Umbilical Cord Matrix-Derived Mesenchymal Stem Cells Activity for many diseases such as Duchenne Muscular Dystrophy, Spinocerebellar ataxia, Friedreich ataxia, Non-progressive congenital myopathy, spinal injury, Retinitis pigmentosa, hypoxic-ischemic encephalopathy, encephalomalacia secondary to head trauma, cerebral palsy and subacute sclerosing panencephalitis (SSPE) that are impossible to treat with today’s known medical methods.
Prof. Karaöz also maintains his academic works as the founding Vice President and as a lecturer at the Faculty of Medicine at Istinye University founded as per the law dated 01.04.2015 and numbered 6642. As the founder of the Stem Cell and Tissue Engineering Research and Application Center at ISU, Prof. Erdal Karaöz carries out his national and international R&D activities at this center while simultaneously conducting the Postgraduate Program of Stem Cell and Tissue Engineering.